CAD 0.05
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.13 CAD | -30.0% |
2022 | -0.10 CAD | -143.9% |
2021 | -0.04 CAD | -2057.89% |
2020 | -0.00 CAD | 0.0% |
2019 | - CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.01 CAD | 62.5% |
2024 Q2 | -0.01 CAD | -44.12% |
2023 Q2 | -0.04 CAD | 20.91% |
2023 FY | - CAD | -30.0% |
2023 Q4 | -0.03 CAD | -31.4% |
2023 Q3 | -0.02 CAD | 50.24% |
2023 Q1 | -0.05 CAD | -101.53% |
2022 Q2 | -0.02 CAD | 18.0% |
2022 Q1 | -0.02 CAD | -42.05% |
2022 Q4 | -0.03 CAD | -94.78% |
2022 FY | - CAD | -143.9% |
2022 Q3 | -0.01 CAD | 34.63% |
2021 Q1 | -0.01 CAD | 0.0% |
2021 FY | - CAD | -2057.89% |
2021 Q3 | -0.01 CAD | -13.7% |
2021 Q4 | -0.02 CAD | -112.05% |
2021 Q2 | -0.01 CAD | -17.74% |
2020 FY | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 71.111% |
BetterLife Pharma Inc. | -0.03 CAD | -392.424% |
BioVaxys Technology Corp. | -0.06 CAD | -126.876% |
ChitogenX Inc. | -0.02 CAD | -510.329% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | -217.073% |
Defence Therapeutics Inc. | -0.30 CAD | 56.667% |
Entheon Biomedical Corp. | -0.05 CAD | -155.906% |
Gemina Laboratories Ltd. | -0.07 CAD | -80.556% |
Glow Lifetech Corp. | -0.03 CAD | -351.389% |
Lexston Life Sciences Corp. | -0.02 CAD | -465.217% |
Pharmala Biotech Holdings Inc. | -0.01 CAD | -1313.043% |
Doseology Sciences Inc. | -0.08 CAD | -63.112% |
MYND Life Sciences Inc. | -0.03 CAD | -304.984% |
Nova Mentis Life Science Corp. | -0.01 CAD | -1466.265% |
PharmaTher Holdings Ltd. | -0.04 CAD | -268.272% |
PreveCeutical Medical Inc. | -0.00 CAD | -5316.667% |
Telescope Innovations Corp. | -0.12 CAD | -8.333% |